Evaluation of the Cozart DDSV test for cannabis in oral fluid

Therapeutic Drug Monitoring

Volumn 31, Issue 1, 2009, Pages 131-134

  Kintz, Pascal ^a   Brunei, Bertrand ^b   Muller, Jean François ^a   Serra, Wilfried ^c   Villain, Marion ^a   Cirimele, Vincent ^a   Mura, Patrick ^b  

^a Laboratoire ChemTox   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c CENTRE HOSPITALIER HENRI LABORIT   (France)

Author keywords

Cannabis; Cozart DDS; On site device; Oral fluid

Indexed keywords

CANNABIS;

ARTICLE; CANNABIS SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SALIVA ANALYSIS; SCREENING TEST;

ADULT; BODY FLUIDS; CALIBRATION; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INDICATORS AND REAGENTS; MALE; MARIJUANA SMOKING; METHYLATION; REPRODUCIBILITY OF RESULTS; SALIVA; SPECIMEN HANDLING; SUBSTANCE ABUSE DETECTION; TETRAHYDROCANNABINOL;

EID: 60449084280     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181947916     Document Type: Article

References (12)

1. Drummer OH. Introduction and review of collection techniques and applications of drug testing of oral fluid. Ther Drug Monit. 2008;30:203-206.
2. Walch JM, Crouch DJ, Danaceau JP, et al. Evaluation of ten oral fluid point-of-collection drug-testing devices. J Anal Toxicol. 2007;31:44-54.
3. Laloup M, Fernandez MDR, Wood M, et al. Correlation of delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Drager DrugTest. Forensic Sci Int. 2006;161:175-179.
4. Raes E, Verstraete A. Evaluation of rapid point-of-collection oral fluid testing devices. In: Verstrate A, Raes E, eds. Rosita-2 Project: Final Report. Gent, Belgium: Academia Press; 2006:227-257.
5. Kintz P, Bernhard W, Villain M, et al. Detection of cannabis use in drivers with the drug-wipe device and by GC/MS after Intercept device collection. J Anal Toxicol. 2005;29:724-727.
6. Cirimele V, Villain M, Mura P, et al. Oral fluid testing for cannabis: on-site Oraline IV s.a.t. device versus GC/MS. Forensic Sci Int. 2006;161: 180-184.
7. Moore C, Rana S, Coulter C, et al. Detection of conjugated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J Anal Toxicol. 2007; 31:187-194.
8. Speedy T, Baldwin D, Jowett G, et al. Development and validation of the Cozart DDS oral fluid collection device. Forensic Sci Int. 2007;170: 117-120.
9. Crouch DJ, Walsh JM, Cangianelli L, et al. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Ther Drug Monit. 2008;30:188-195.
10. SAMHSA. Proposed guidelines for mandatory drug testing. Fed Regist. 2004;69:19673-19731.
11. Drummer OH. Review: pharmacokinetics of illicit drugs in oral fluid. Forensic Sci Int. 2005;150:133-142.
12. Kauert GF, Ramaekers JG, Schneider E, et al. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol. 2007;31:288-293.